In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates | Zendy

Emilia Cercenado | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates

Author(s) -

Emilia Cercenado

Publication year - 2001

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/47.1.77

Subject(s) - teicoplanin , linezolid , microbiology and biotechnology , vancomycin , penicillin , antibiotics , glycopeptide , erythromycin , in vitro , biology , staphylococcus aureus , bacteria , biochemistry , genetics

The in vitro activity of the oxazolidinone linezolid was compared with the activities of vancomycin and teicoplanin against 450 Gram-positive clinical isolates, including a variety of multiply resistant strains. Linezolid inhibited all microorganisms tested at < or = 4 mg/L, including methicillin- and teicoplanin-resistant staphylococci, glycopeptide-resistant enterococci, penicillin- and multiply resistant pneumococci and viridans streptococci, and erythromycin-resistant beta-haemolytic streptococci. The MIC(90) of linezolid for all isolates was 2 mg/L.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research